Twist Bioscience

Company Overview

Twist Bioscience develops and commercializes next-generation platforms for DNA synthesis. It has developed a proprietary silicon-based DNA synthesis platform that enables the production of high-quality synthetic DNA with greater precision, lower cost, and higher throughput than traditional techniques. Twist is leveraging its gene synthesis platform to create products in other fields, including NGS enrichment and DNA libraries. It also markets kits for NGS enrichment, oligo pools, and DNA libraries. It provides services to clients across biotechnology, pharmaceuticals, academia, agriculture, industrial chemicals, and diagnostics.

Financial Highlights (FY 2025)

Company's Business Segments

• Synthetic genes : Clonal genes of perfect quality are delivered to the customer in a vector vehicle. Genes that customers can place in their own vector, non-clonal genes or fragments.
• Oligo pools : Oligo pools ranging from a few hundred oligos to over one million Offer oligonucleotides of up to 300 nucleotides in length with an error rate of 1:3000 nucleotides.
• DNA libraries : Single-site libraries, Antibody optimization solution, Custom software for the optimization of antibody hits, Antibody compounds that meet pre-specified criteria for therapeutic Development.
• Antibody discovery : Antigen Production, Diversimab Platform, VHH Discovery, Antibody Discovery, Antibody Sequencing.
• NGS tools : This segment includes DNA synthesis platform.